103 related articles for article (PubMed ID: 32308220)
1. China's Coronavirus-Induced Paralysis Threatens U.S. Drug Supply Chain.
Miller HI; Cohrssen JJ
Mo Med; 2020; 117(2):86-88. PubMed ID: 32308220
[No Abstract] [Full Text] [Related]
2. Medication Shortages During the COVID-19 Crisis: What We Must Do.
Choo EK; Rajkumar SV
Mayo Clin Proc; 2020 Jun; 95(6):1112-1115. PubMed ID: 32312491
[No Abstract] [Full Text] [Related]
3. COVID-19 will further exacerbate global antimicrobial resistance.
Yam ELY
J Travel Med; 2020 Sep; 27(6):. PubMed ID: 32539142
[No Abstract] [Full Text] [Related]
4. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
[No Abstract] [Full Text] [Related]
5. Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?
Lasheras I; Santabárbara J
Med Clin (Barc); 2020 Jul; 155(1):23-25. PubMed ID: 32386744
[No Abstract] [Full Text] [Related]
6. [Glucocorticoid for coronavirus disease 2019: a dilemma].
Du X; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):278. PubMed ID: 32385989
[No Abstract] [Full Text] [Related]
7. Pandemic chain of survival: Gathering strength to revive our societies.
Buléon C; Minehart RD; Bergot E; Chan A; Fischer MO
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):547-548. PubMed ID: 32745633
[No Abstract] [Full Text] [Related]
8. After Coronavirus Disease 2019.
Wenzel RP
Clin Infect Dis; 2020 Sep; 71(6):1365-1366. PubMed ID: 32301956
[No Abstract] [Full Text] [Related]
9. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
10. Hospital pharmacy in COVID-19.
Claramunt-García R; Muñoz-Cid CL; Sierra-Torres MI; Merino-Almazán M
Farm Hosp; 2020 Jun; 44(7):74. PubMed ID: 32533677
[No Abstract] [Full Text] [Related]
11. COVID-19 Pandemic - Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis?
Kumar Y; Jain A
Curr Top Med Chem; 2020; 20(16):1438-1439. PubMed ID: 32394840
[No Abstract] [Full Text] [Related]
12. Allocation of pharmaceutical resources in maternal and child healthcare institutions during the COVID-19 pandemic.
Cai J; Chen W; Yang X; Yang X; Li G
Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):41-47. PubMed ID: 32965355
[TBL] [Abstract][Full Text] [Related]
13. Health Care Supply Chains: COVID-19 Challenges and Pressing Actions.
Mirchandani P
Ann Intern Med; 2020 Aug; 173(4):300-301. PubMed ID: 32369540
[TBL] [Abstract][Full Text] [Related]
14. Administration of end-of-life drugs by family caregivers during covid-19 pandemic.
Bowers B; Pollock K; Barclay S
BMJ; 2020 Apr; 369():m1615. PubMed ID: 32332027
[No Abstract] [Full Text] [Related]
15. Anticoagulation in COVID-19: DDI Perspective.
Khiali S; Entezari-Maleki T
Clin Appl Thromb Hemost; 2020; 26():1076029620959457. PubMed ID: 32936672
[No Abstract] [Full Text] [Related]
16. Meta-analysis of Effect of Statins in Patients with COVID-19.
Kow CS; Hasan SS
Am J Cardiol; 2020 Nov; 134():153-155. PubMed ID: 32891399
[No Abstract] [Full Text] [Related]
17. [Not Available].
Nau JY
Rev Med Suisse; 2020 Apr; 16(N° 691-2):876-877. PubMed ID: 32348059
[No Abstract] [Full Text] [Related]
18. Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
Polansky H; Lori G
J Evid Based Integr Med; 2020; 25():2515690X20932523. PubMed ID: 32551855
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(698):1272-1273. PubMed ID: 32558461
[No Abstract] [Full Text] [Related]
20. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
Ayaz S; Crea F
Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
